본문 바로가기
KERD
논문KCI 등재

Immune regulation through tryptophan metabolism

권병석|서수길
생화학분자생물학회 (Korean Society Of Biochemistry And Molecular Biology)|2023.12|Experimental and Molecular Medicine|제55권 |pp. 1371-1379|DOI 10.1038/s12276-023-01028-7

1

조회

0

다운로드

0

인용

0

참고문헌

주제분류생화학

초록

Amino acids are fundamental units of molecular components that are essential for sustaining life; however, their metabolism is closely interconnected to the control systems of cell function. Tryptophan (Trp) is an essential amino acid catabolized by complex metabolic pathways. Several of the resulting Trp metabolites are bioactive and play central roles in physiology and pathophysiology. Additionally, various physiological functions of Trp metabolites are mutually regulated by the gut microbiota and intestine to coordinately maintain intestinal homeostasis and symbiosis under steady state conditions and during the immune response to pathogens and xenotoxins. Cancer and inflammatory diseases are associated with dysbiosis- and host-related aberrant Trp metabolism and inactivation of the aryl hydrocarbon receptor (AHR), which is a receptor of several Trp metabolites. In this review, we focus on the mechanisms through which Trp metabolism converges to AHR activation for the modulation of immune function and restoration of tissue homeostasis and how these processes can be targeted using therapeutic approaches for cancer and inflammatory and autoimmune diseases.

Abstract

Amino acids are fundamental units of molecular components that are essential for sustaining life; however, their metabolism is closely interconnected to the control systems of cell function. Tryptophan (Trp) is an essential amino acid catabolized by complex metabolic pathways. Several of the resulting Trp metabolites are bioactive and play central roles in physiology and pathophysiology. Additionally, various physiological functions of Trp metabolites are mutually regulated by the gut microbiota and intestine to coordinately maintain intestinal homeostasis and symbiosis under steady state conditions and during the immune response to pathogens and xenotoxins. Cancer and inflammatory diseases are associated with dysbiosis- and host-related aberrant Trp metabolism and inactivation of the aryl hydrocarbon receptor (AHR), which is a receptor of several Trp metabolites. In this review, we focus on the mechanisms through which Trp metabolism converges to AHR activation for the modulation of immune function and restoration of tissue homeostasis and how these processes can be targeted using therapeutic approaches for cancer and inflammatory and autoimmune diseases.

참고문헌 (110)

  1. Cervenka, I., "Kynurenines: tryptophan’s metabolites in exercise, inflammation, and mental health", Science, 357, pp.eaaf9794~ (2017)
  2. Zelante, T., "Tryptophan catabolites from microbiota engage aryl hydrocarbon receptor and balance mucosal reactivity via interleukin-22", Immunity, 39, pp.372~385 (2013)
  3. Uberoi, A., "Commensal microbiota regulates skin barrier function and repair via signaling through the aryl hydrocarbon receptor", Cell Host Microbe, 29, pp.1235~1248 (2021)
  4. Stockinger, B., "AHR in the intestinal microenvironment : safeguarding barrier function", Nat. Rev. Gastroenterol. Hepatol, 18, pp.559~570 (2021)
  5. Metidji, A., "The environmental sensor AHR protects from inflammatory damage by maintaining intestinal stem cell homeostasis and barrier integrity", Immunity, 49, pp.353~362 (2018)
  6. Badawy, A. A. B., "Tryptophan metabolism and disposition in cancer biology and immunotherapy", Biosci. Rep, 42, pp.BSR20221682~ (2022)
  7. Joisten, N., "The kynurenine pathway in chronic diseases: a compensatory mechanism or a driving force?", Trends Mol. Med, 27, pp.946~954 (2021)
  8. Feng, S., "Role of aryl hydrocarbon receptor in cancer", Biochim. Biophys. Acta Rev. Cancer, 1836, pp.197~210 (2013)
  9. Opitz, C. A., "The therapeutic potential of targeting tryptophan catabolism in cancer", Br. J. Cancer, 122, pp.30~44 (2020)
  10. Lemos, H., "Immune control by amino acid catabolism during tumorigenesis and therapy", Nat. Rev. Cancer, 19, pp.162~175 (2019)
  11. Gargaro, M., "Indoleamine 2, 3-dioxygenase 1 activation in mature cDC1promotes tolerogenic education of inflammatory cDC2 via metabolic communication", Immunity, 55, pp.1032~1050 (2022)
  12. Pallotta, M. T., "Indoleamine 2, 3-dioxygenase is a signaling protein in longterm tolerance by dendritic cells", Nat. Immunol, 12, pp.870~878 (2011)
  13. Bessede, A., "Aryl hydrocarbon receptor control of a disease tolerance defence pathway", Nature, 511, pp.184~190 (2014)
  14. Mondanelli, G., "A relay pathway between arginine and tryptophan metabolism confers immunosuppressive properties on dendritic cells", Immunity, 46, pp.233~244 (2017)
  15. Grohmann, U., "CTLA-4–Ig regulates tryptophan catabolism in vivo", Nat. Immunol, 3, pp.1097~1101 (2002)
  16. Fallarino, F., "Modulation of tryptophan catabolism by regulatory T cells", Nat. Immunol, 4, pp.1206~1212 (2003)
  17. Grohmann, U., "Reverse signaling through GITR ligand enables dexamethasone to activate IDO in allergy", Nat. Med, 13, pp.579~586 (2007)
  18. Sadik, A., "IL4I1 is a metabolic immune checkpoint that activates the AHR and promotes tumor progression", Cell, 182, pp.1252~1270 (2020)
  19. Kimura, A., "Aryl hydrocarbon receptor in combination with Stat1 regulates LPS-induced inflammatory responses", J. Exp. Med, 206, pp.2027~2035 (2009)
  20. Di Meglio, P., "Activation of the aryl hydrocarbon receptor dampens the severity of inflammatory skin conditions", Immunity, 40, pp.989~1001 (2014)
  21. Lee, S. -M., "Aryl hydrocarbon receptor–targeted therapy for CD4+ T cell–mediated idiopathic pneumonia syndrome in mice", Blood, 139, pp.3325~3339 (2022)
  22. Iyoda, T., "The CD8+ dendritic cell subset selectively endocytoses dying cells in culture and in vivo", J. Exp. Med, 195, pp.1289~1302 (2002)
  23. Hongo, D., "Tolerogenic interactions between CD8+ dendritic cells and NKT cells prevent rejection of bone marrow and organ grafts", Blood, 129, pp.1718~1728 (2017)
  24. Brown, C. C., "Transcriptional basis of mouse and human dendritic cell heterogeneity", Cell, 179, pp.846~863 (2019)
  25. Barroso, A., "Therapeutic induction of tolerogenic dendritic cells via aryl hydrocarbon receptor signaling", Curr. Opin. Immunol, 70, pp.33~39 (2021)
  26. Maier, "A conserved dendritic-cell regulatory program limits antitumor immunity", Nature, 580, pp.257~262 (2020)
  27. Wang, J., "Single-cell multiomics defines tolerogenic extrathymic Aireexpressing populations with unique homology to thymic epithelium", Sci. Immunol, 6, pp.eabl5053~ (2021)
  28. Takenaka, M. C., "Control of tumor-associated macrophages and T cells in glioblastoma via AHR and CD39", Nat. Neurosci, 22, pp.729~740 (2019)
  29. Campesato, L. F., "Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine", Nat. Commun, 11, pp.4011~ (2020)
  30. Quintana, F. J., "Control of Treg and TH17 cell differentiation by the aryl hydrocarbon receptor", Nature, 453, pp.65~71 (2008)
  31. Nguyen, N. T., "Aryl hydrocarbon receptor negatively regulates dendritic cell immunogenicity via a kynurenine-dependent mechanism", Proc. Natl Acad. Sci. USA, 107, pp.19961~19966 (2010)
  32. Mucida, D., "Reciprocal TH17 and regulatory T cell differentiation mediated by retinoic acid", Science, 317, pp.256~260 (2007)
  33. Coombes, J. L., "A functionally specialized population of mucosal CD103+DCs induces Foxp3+ regulatory T cells via a TGF-β– and retinoic acid–dependent mechanism", J. Exp. Med, 204, pp.1757~1764 (2007)
  34. Jaensson, E., "Small intestinal CD103+ dendritic cells display unique functional properties that are conserved between mice and humans", J. Exp. Med, 205, pp.2139~2149 (2008)
  35. McGovern, K., "Discovery and characterization of a novel aryl hydrocarbon receptor inhibitor, IK-175, and its inhibitory activity on tumor immune suppression", Mol. Cancer Ther, 21, pp.1261~1272 (2022)
  36. Liu, Y., "Tumor-repopulating cells induce PD-1 expression in CD8+ T cells by transferring kynurenine and AhR activation", Cancer Cell, 33, pp.480~494 (2018)
  37. Liu, Y., "IL-2 regulates tumor-reactive CD8+ T cell exhaustion by activating the aryl hydrocarbon receptor", Nat. Immunol, 22, pp.358~369 (2021)
  38. Corgnac, S., "CD103+CD8+ TRM cells accumulate in tumors of anti-PD-1-responder lung cancer patients and are tumor-reactive lymphocytes enriched with Tc17", Cell Rep. Med, 1, pp.100127~ (2020)
  39. St. Paul, M., "IL6 induces an IL22+ CD8+ T-cell subset with potent antitumor function", Cancer Immunol. Res, 8, pp.321~333 (2020)
  40. Shin, J. H., "Modulation of natural killer cell antitumor activity by the aryl hydrocarbon receptor", Proc. Natl Acad. Sci. USA, 110, pp.12391~12396 (2013)
  41. Shin, J. H., "AHR regulates NK cell migration via ASB2–mediated ubiquitination of filamin A", Front. Immunol, 12, pp.624284~ (2021)
  42. Munn, D. H., "GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2, 3-dioxygenase", Immunity, 22, pp.633~642 (2005)
  43. Fallarino, F., "The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor ζ-chain and induce a regulatory phenotype in naive T cells1", J. Immunol, 176, pp.6752~6761 (2006)
  44. Pallotta, M. T., "Indoleamine 2, 3-dioxygenase 1(IDO1) : an up-to-date overview of an eclectic immunoregulatory enzyme", FEBS J, 289, pp.6099~6118 (2022)
  45. Halaby, M. J., "GCN2 drives macrophage and MDSC function and immunosuppression in the tumor microenvironment", Sci. Immunol, 4, pp.eaax8189~ (2019)
  46. Ravishankar, B., "The amino acid sensor GCN2 inhibits inflammatory responses to apoptotic cells promoting tolerance and suppressing systemic autoimmunity", Proc. Natl Acad. Sci. USA, 112, pp.10774~10779 (2015)
  47. Cobbold, S. P., "Infectious tolerance via the consumption of essential amino acids and mTOR signaling", Proc. Natl Acad. Sci. USA, 106, pp.12055~12060 (2009)
  48. Sharma, M. D., "The PTEN pathway in Tregs is a critical driver of the suppressive tumor microenvironment", Sci. Adv, 1, pp.e1500845~ (2015)
  49. Ye, J., "GCN2 sustains mTORC1 suppression upon amino acid deprivation by inducing Sestrin2", Genes Dev, 29, pp.2331~2336 (2015)
  50. Munn, D. H., "IDO in the tumor microenvironment : inflammation, counter-regulation, and tolerance", Trends Immunol, 37, pp.193~207 (2016)
  51. Sharma, M. D., "Inhibition of the BTK-IDO-mTOR axis promotes differentiation of monocyte-lineage dendritic cells and enhances anti-tumor T cell immunity", Immunity, 54, pp.2354~2371 (2021)
  52. Metz, R., "IDO inhibits a tryptophan sufficiency signal that stimulates mTOR : a novel IDO effector pathway targeted by D-1-methyl-tryptophan", Oncoimmunology, 1, pp.1460~1468 (2012)
  53. Adam, I., "Upregulation of tryptophanyl-tRNA synthethase adapts human cancer cells to nutritional stress caused by tryptophan degradation", OncoImmunology, 7, pp.e1486353~ (2018)
  54. Lee, S. -M., "Inhibition of acute lethal pulmonary inflammation by the IDO–AhR pathway", Proc. Natl Acad. Sci. USA, 114, pp.E5881~E5890 (2017)
  55. Schiering, C., "Feedback control of AHR signalling regulates intestinal immunity", Nature, 542, pp.242~245 (2017)
  56. Kiss, E. A., "Natural aryl hydrocarbon receptor ligands control organogenesis of intestinal lymphoid follicles", Science, 334, pp.1561~1565 (2011)
  57. Lee, J. S., "AHR drives the development of gut ILC22 cells and postnatal lymphoid tissues via pathways dependent on and independent of Notch", Nat. Immunol, 13, pp.144~151 (2012)
  58. Li, Y., "Exogenous stimuli maintain intraepithelial lymphocytes via aryl hydrocarbon receptor activation", Cell, 147, pp.629~640 (2011)
  59. Qiu, J., "The aryl hydrocarbon receptor regulates gut immunity through modulation of innate lymphoid cells", Immunity, 36, pp.92~104 (2012)
  60. Gagliani, N., "Th17 cells transdifferentiate into regulatory T cells during resolution of inflammation", Nature, 523, pp.221~225 (2015)
  61. Apetoh, L., "The aryl hydrocarbon receptor interacts with c-Maf to promote the differentiation of type 1 regulatory T cells induced by IL-27", Nat. Immunol, 11, pp.854~861 (2010)
  62. Mascanfroni, I. D., "IL-27 acts on DCs to suppress the T cell response and autoimmunity by inducing expression of the immunoregulatory molecule CD39", Nat. Immunol, 14, pp.1054~1063 (2013)
  63. Mascanfroni, I. D., "Metabolic control of type 1 regulatory T cell differentiation by AHR and HIF1-α", Nat. Med, 21, pp.638~646 (2015)
  64. Tousa, S., "Activin-A co-opts IRF4 and AhR signaling to induce human regulatory T cells that restrain asthmatic responses", Proc. Natl Acad. Sci. USA, 114, pp.E2891~E2900 (2017)
  65. Hong, C. -H., "Selective AhR knockout in langerin-expressing cells abates Langerhans cells and polarizes Th2", Tr1 in epicutaneous protein sensitization, 2020, pp.117, 12980~12990
  66. Grohmann, U., "A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice", J. Exp. Med, 198, pp.153~160 (2003)
  67. Pallotta, M. T., "Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes", J. Cell Mol. Med, 18, pp.2082~2091 (2014)
  68. Anquetil, F., "Loss of IDO1 expression from human pancreatic β-cells precedes their destruction during the development of type 1 diabetes", Diabetes, 67, pp.1858~1866 (2018)
  69. Orabona, C., "Deficiency of immunoregulatory indoleamine 2, 3-dioxygenase 1 in juvenile diabetes", JCI Insight, 3, pp.e96244~ (2018)
  70. Seo, S. K., "4-1BB-mediated immunotherapy of rheumatoid arthritis", Nat. Med, 10, pp.1088~1094 (2004)
  71. Mondanelli, G., "Positive allosteric modulation of indoleamine 2, 3-dioxygenase 1 restrains neuroinflammation", Proc. Natl Acad. Sci. USA, 117, pp.3848~3857 (2020)
  72. Orabona, C., "SOCS3 drives proteasomal degradation of indoleamine 2, 3-dioxygenase(IDO)and antagonizes IDO-dependent tolerogenesis", Proc. Natl Acad. Sci. USA, 105, pp.20828~20833 (2008)
  73. Ravishankar, B., "Marginal zone CD169+ macrophages coordinate apoptotic cell-driven cellular recruitment and tolerance", Proc. Natl Acad. Sci. USA, 111, pp.4215~4220 (2014)
  74. Ravishankar, B., "Tolerance to apoptotic cells is regulated by indoleamine 2, 3-dioxygenase", Proc. Natl Acad. Sci. USA, 109, pp.3909~3914 (2012)
  75. Shinde, R., "Apoptotic cell–induced AhR activity is required for immunological tolerance and suppression of systemic lupus erythematosus in mice and humans", Nat. Immunol, 19, pp.571~582 (2018)
  76. Fiore, A., "Kynurenine importation by SLC7A11 propagates anti-ferroptotic signaling", Mol. Cell, 82, pp.920~932 (2022)
  77. Zeitler, L., "Anti-ferroptotic mechanism of IL4i1-mediated amino acid metabolism", Elife, 10, pp.e64806~ (2021)
  78. Wang, J., "Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35*", J. Biol. Chem, 281, pp.22021~22028 (2006)
  79. Fallarini, S., "Expression of functional GPR35 in human iNKT cells", Biochem. Biophys. Res. Commun, 398, pp.420~425 (2010)
  80. Sun, T., "Kynurenic acid ameliorates NLRP3 inflammasome activation by blocking calcium mobilization via GPR35", Front. Immunol, 13, pp.1019365~ (2022)
  81. De Giovanni, M., "GPR35 promotes neutrophil recruitment in response to serotonin metabolite 5-HIAA", Cell, 185, pp.815~830 (2022)
  82. Agudelo, L. Z., "Kynurenic acid and Gpr35 regulate adipose tissue energy homeostasis and inflammation", Cell Metab, 27, pp.378~392 (2018)
  83. Agudelo, L. Z., "Skeletal muscle PGC-1α1 reroutes kynurenine metabolism to increase energy efficiency and fatigue-resistance", Nat. Commun, 10, pp.2767~ (2019)
  84. Wyant, G. A., "Mitochondrial remodeling and ischemic protection by G protein–coupled receptor 35 agonists", Science, 377, pp.621~629 (2022)
  85. Molinier-Frenkel, V., "The IL4I1 enzyme : a new player in the immunosuppressive tumor microenvironment", Cells, 8, pp.757~ (2019)
  86. Riaz, N., "Tumor and microenvironment evolution during immunotherapy with nivolumab", Cell, 171, pp.934~949 (2017)
  87. Amaria, R. N., "Neoadjuvant systemic therapy in melanoma : recommendations of the International Neoadjuvant Melanoma Consortium", Lancet Oncol, 20, pp.e378~e389 (2019)
  88. Long, G. V., "Epacadostat plus pembrolizumab versus placebo plus pembrolizumab in patients with unresectable or metastatic melanoma(ECHO-301", KEYNOTE-252) : a phase 3, randomised, double-blind study, 2019, pp.20, 1083~1097
  89. Aubatin, A., "IL4-induced gene 1 is secreted at the immune synapse and modulates TCR activation independently of its enzymatic activity", Eur. J. Immunol, 48, pp.106~119 (2018)
  90. Zilionis, R., "Single-cell transcriptomics of human and mouse lung cancers reveals conserved myeloid populations across individuals and species", Immunity, 50, pp.1317~1334 (2019)
  91. Gerhard, G. M., "Tumorinfiltrating dendritic cell states are conserved across solid human cancers", J. Exp. Med, 218, pp.e20200264~ (2020)
  92. Cheng, S., "A pan-cancer single-cell transcriptional atlas of tumor infiltrating myeloid cells", Cell, 184, pp.792~809 (2021)
  93. Di Pilato, M., "CXCR6 positions cytotoxic T cells to receive critical survival signals in the tumor microenvironment", Cell, 184, pp.4512~4530 (2021)
  94. Domínguez Conde, C., "Cross-tissue immune cell analysis reveals tissuespecific features in humans", Science, 376, pp.eabl5197~ (2022)
  95. Liu, Y., "Tumour heterogeneity and intercellular networks of nasopharyngeal carcinoma at single cell resolution", Nat. Commun, 12, pp.741~ (2021)
  96. Hezaveh, K., "Tryptophan-derived microbial metabolites activate the aryl hydrocarbon receptor in tumor-associated macrophages to suppress anti-tumor immunity", Immunity, 55, pp.324~340 (2022)
  97. Renga, G., "Optimizing therapeutic outcomes of immune checkpoint blockade by a microbial tryptophan metabolite", J. Immunother. Cancer, 10, pp.e003725~ (2022)
  98. Rothhammer, V., "Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor", Nat. Med, 22, pp.586~597 (2016)
  99. Rothhammer, V., "Microglial control of astrocytes in response to microbial metabolites", Nature, 557, pp.724~728 (2018)
  100. Lamas, B., "CARD9 impacts colitis by altering gut microbiota metabolism of tryptophan into aryl hydrocarbon receptor ligands", Nat. Med, 22, pp.598~605 (2016)
  101. Natividad, J. M., "Impaired aryl hydrocarbon receptor ligand production by the gut microbiota is a key factor in metabolic syndrome", Cell Metab, 28, pp.737~749 (2018)
  102. Karmakar, S., "Role of serotonin receptor signaling in cancer cells and anti-tumor immunity", Theranostics, 11, pp.5296~5312 (2021)
  103. Odunsi, K., "Metabolic adaptation of ovarian tumors in patients treated with an IDO1 inhibitor constrains antitumor immune responses", Sci. Transl. Med, 14, pp.eabg8402~ (2022)
  104. Duerschmied, D., "Platelet serotonin promotes the recruitment of neutrophils to sites of acute inflammation in mice", Blood, 121, pp.1008~1015 (2013)
  105. Haq, S., "Tryptophan-derived serotonin-kynurenine balance in immune activation and intestinal inflammation", FASEB J, 35, pp.e21888~ (2021)
  106. Varelias, A., "Lung parenchyma-derived IL-6 promotes IL-17A–dependent acute lung injury after allogeneic stem cell transplantation", Blood, 125, pp.2435~2444 (2015)
  107. Park, H. Y., "Priming mesenchymal stem", stromal cells with a combination of a low dose of IFN-γ and bortezomib results in potent suppression of pathogenic Th17 immunity through the IDO1-AHR Axis, 2022, pp.41, sxac075~
  108. Kenison, J. E., "Tolerogenic nanoparticles suppress central nervous system inflammation", Proc. Natl Acad. Sci. USA, 117, pp.32017~32028 (2020)
  109. Chen, J., "Modulation of lymphocyte-mediated tissue repair by rational design of heterocyclic aryl hydrocarbon receptor agonists", Sci. Adv, 6, pp.eaay8230~ (2020)
  110. Mills, K. H. G., "IL-17 and IL-17-producing cells in protection versus pathology", Nat. Rev. Immunol, 23, pp.38~54 (2023)

관련 논문AI추천

Aromatic Amino Acid Metabolites: Molecular Messengers Bridging Immune-Microbiota Communication방예지, Hyun-Ki Shin대한면역학회 · Immune Network2025 · 제25권 제1호Indole Propionic Acid Regulates Gut Immunity: Mechanisms of Metabolite-Driven Immunomodulation and Barrier IntegrityBao Yuwen, Li Dihao, Li Xinze, Pan Lijia, Ren Tao, Sun Feng, Wang Ao, Yue Hao, Zhang Meiyu, Zheng Fei한국미생물·생명공학회 · Journal of Microbiology and Biotechnology2025 · 제35권 Gut Microbial Metabolites on Host Immune Responses in Health and Disease권호근, 도준수, 윤종휘, 이충구, Velankanni Priyanka대한면역학회 · Immune Network2023 · 제23권 제1호Gut Microbiota-Derived Short-Chain Fatty Acids, T Cells, and Inflammation김명후, 김창한, 박정호대한면역학회 · Immune Network2014 · 제14권 제6호Integrative understanding of immune-metabolic interaction홍준영, Hawon Kim, Hyeon Yang, Myunghyun Jeong, Seonyoung Im생화학분자생물학회 · BMB Reports2022 · 제55권 제6호The Specific Roles of Vitamins in the Regulation of Immunosurveillance and Maintenance of Immunologic Homeostasis in the GutJun Kunisawa, Koji Hosomi대한면역학회 · Immune Network2017 · 제17권 제1호

이 간행물의 다른 논문 (225건)

Endothelial senescence in vascular diseases: current understanding and future opportunities in senotherapeutics김성영, Han Yeaeunpp. 1-12Grave-to-cradle: human embryonic lineage tracing from the postmortem bodyKu Eu Jeong, Choi Seock Hwan, Choi Yujin Angelina, Oh Ji Wonpp. 13-21Chromatin and noncoding RNA-mediated mechanisms of gastric tumorigenesisKim Tae-Hee, Loe Adrian Kwan Ho, Zhu Lexinpp. 22-31TPX2 prompts mitotic survival via the induction of BCL2L1 through YAP1 protein stabilization in human embryonic stem cellsCha Hyuk-Jin, Kim Yun-Jeong, Go Young-Hyun, 정호창, Kwon Eun-Ji, Kim Seong-Min, Cheong Hyun Sub, Kim Wantae, Shin Hyoung Doo, Lee Haeseungpp. 32-42ZBTB7A suppresses glioblastoma tumorigenesis through the transcriptional repression of EPB41L5Nam Hae Yun, 김성학, 김승후, 최경철, Park Seung-Ho, Song Ji-Hye, Jeong Ji-Hoon, Kim Hyunhee, Jeong Minseok, Kong Min-Jeong, Son Jihyun, Jeong Ji-Eunpp. 43-54
원문 보기